- Article
- Published:
Association of a chromosome deletion syndrome with a fragile site within the proto-oncogene CBL2
- C. Jones 1 ,
- L. Penny 2 ,
- T. Mattina 3 ,
- S. Yu 4 ,
- E. Baker 4 ,
- L. Voullaire 5 ,
- W. Y. Langdon 6 ,
- G. R. Sutherland 4 ,
- R. I. Richards 4 &
- ...
- A. Tunnacliffe 7
Nature volume 376, pages 145–149 (1995)Cite this article
-
671 Accesses
-
174 Citations
-
3 Altmetric
Abstract
The fragile site FRA11B has been localized to the p(CCG)n repeat of the CBL2 proto-oncogene. A proportion of Jacobsen (11q−) syndrome patients inherited a chromosome carrying a CBL2 p(CCG)n expansion, which was truncated close to FRA11B. These results have broad implications for the role of p(CCG)n repeat expansion in the aetiology of genetic disease involving chromosome rearrangements.
This is a preview of subscription content, access via your institution
Access options
Subscription info for Japanese customers
We have a dedicated website for our Japanese customers. Please go to natureasia.com to subscribe to this journal.
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
\ 4,980
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Gene editing of NCF1 loci is associated with homologous recombination and chromosomal rearrangements
Genomic Balancing Act: deciphering DNA rearrangements in the complex chromosomal aberration involving 5p15.2, 2q31.1, and 18q21.32
Chromothripsis as an on-target consequence of CRISPR–Cas9 genome editing
References
Sutherland, G. R. & Hecht, F. Fragile Sites On Human Chromosomes (Oxford Univ. Press, Oxford, 1985).
Warren, S. T., Zhang, F., Licameli, G. R. & Peters, J. F. Science 237, 420–423 (1987).
Yu, S. et al. Science 252, 1179–1182 (1991).
Verkerk, A. J. M. H. et al. Cell 65, 905–914 (1991).
Kremer, E. J. et al. Science 252, 1711–1714 (1991).
Fu, Y.-H. et al. Cell 67, 1047–1058 (1991).
Knight, S. J. et al. Cell 74, 127–134 (1993).
Parrish, J. E. et al. Nature Genet. 8, 229–235 (1994).
Nancarrow, J. K. et al. Science 264, 1938–1941 (1994).
Giraud, F., Aymè, S., Mattei, J. F. & Mattei, M. G. Hum. Genet. 34, 125–136 (1976).
Harvey, J., Judge, C. & Wiener, S. J. med. Genet. 14, 46–50 (1977).
Brown, W. T. & Jenkins, E. C. Molec. Genet. Med. 2, 39–66 (1992).
Flynn, G. A. et al. J. med. Genet. 30, 97–100 (1993).
Mulley, J. C. et al. J. med. Genet. 32, 162–169 (1995).
Bell, M. V. et al. Cell 64, 861–866 (1991).
Oberle, I. et al. Science 252, 1097–1102 (1991).
Vincent, A. et al. Nature 349, 624–626 (1991).
Pieretti, M. et al. Cell 66, 817–822 (1991).
Devys, D., Lutz, Y., Rouyer, N., Bellocq, J. P. & Mandel, J. L. Nature Genet. 4, 335–340 (1993).
Richards, R. I. & Sutherland, G. R. Cell 70, 709–712 (1992).
Blake, T. J., Shapiro, M., Morse, H. C. & Langdon, W. Y. Oncogene 6, 653–657 (1991).
Savage, P. D. et al. Cytogenet. cell. Genet. 56, 112–115 (1991).
Tunnacliffe, A. & McGuire, R. S. Genomics 8, 447–453 (1990).
Sutherland, G. R., Jacky, P. B., Baker, E. & Manuel, A. Am. J. hum. Genet. 35, 432–437 (1983).
Jones, C. et al. Hum. molec. Genet. 3, 2123–2130 (1994).
Voullaire, L. E., Webb, G. C. & Leversha, M. A. Hum. Genet. 76, 202–204 (1987).
Rousseau, F. et al. New Engl. J. Med. 325, 1673–1681 (1991).
Jacobsen, P. et al. Hum. Hered. 23, 568–585 (1973).
Schinzel, A., auf der Maur, P. & Moser, H. J. med. Genet. 14, 438–444 (1977).
Penny, L. A. et al. Am. J. hum. Genet. 56, 676–683 (1995).
Hummerich, H. et al. Hum. molec. Genet. 3, 73–78 (1994).
Willems, P. J. Nature Genet. 8, 213–215 (1994).
Warren, S. T. et al. Proc. natn. Acad. Sci. U.S.A. 87, 3856–3860 (1990).
Donovan, J. A., Wange, R. L., Langdon, W. Y. & Samelson, L. E. J. biol. Chem. 269, 22921–22924 (1994).
Andoniou, C. E., Thien, C. B. F. & Langdon, W. Y. EMBO J. 13, 4515–4523 (1994).
Knudson, A. G. Adv. Cancer Res. 17, 317–324 (1973).
Yunis, J. J. Science 221, 227–236 (1983).
Fishel, R. et al. Cell 75, 1027–1038 (1993).
Leach, F. S. et al. Cell 75, 1215–1225 (1993).
Bronner, C. E. et al. Nature 368, 258–261 (1994).
Papadopoulos, N. et al. Science 263, 1625–1629 (1994).
Thibodeau, S. N., Bren, G. & Schaid, D. Science 260, 816–819 (1993).
Peltomäki, P. et al. Cancer Res. 53, 5853–5855 (1993).
Mao, L. et al. Proc. natn. Acad. Sci. U.S.A. 91, 9871–9875 (1994).
Gyapay, G. et al. Nat. Genet. 7, 246–339 (1994).
Sambrook, J., Fritsch, E. F. & Maniatis, T. Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory, Cold Spring Harbor, 1989).
Rights and permissions
About this article
Cite this article
Jones, C., Penny, L., Mattina, T. et al. Association of a chromosome deletion syndrome with a fragile site within the proto-oncogene CBL2. Nature 376, 145–149 (1995). https://doi.org/10.1038/376145a0
Issue date:
DOI: https://doi.org/10.1038/376145a0
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
This article is cited by
-
Molecular mechanisms underlying nucleotide repeat expansion disorders
- Indranil Malik
- Chase P. Kelley
- Peter K. Todd
Nature Reviews Molecular Cell Biology (2021)
-
Abundancy of polymorphic CGG repeats in the human genome suggest a broad involvement in neurological disease
- Dale J. Annear
- Geert Vandeweyer
- R. Frank Kooy
Scientific Reports (2021)
-
Exploring the Potential of Small Molecule-Based Therapeutic Approaches for Targeting Trinucleotide Repeat Disorders
- Arun Kumar Verma
- Eshan Khan
- Amit Kumar
Molecular Neurobiology (2020)
-
Functional repetitive sequences and fragile sites in chromosomes of Lolium perenne L.
- Laiane Corsini Rocha
- Fernanda de Oliveira Bustamante
- Vânia Helena Techio
Protoplasma (2015)
-
Prenatal diagnosis of a de novo interstitial deletion of 11q (11q22.3 → q23.3) associated with abnormal ultrasound findings by array comparative genomic hybridization
- Nian Liu
- Jiong Yan
- Yanyi Yao
Molecular Cytogenetics (2014)